Cardiopulmonary exercise testing parameters in healthy athletes vs. equally fit individuals with hypertrophic cardiomyopathy
Even in the setting of similar and supranormal pV˙O2, ventilatory efficiency is worse in HCM participants vs. healthy athletes. Our results demonstrate the utility of CPET beyond pV˙O2 assessment in 'grey zone' athlete cases in which the diagnosis of HCM is being debated.
Authors
- Kevin Boyd
- Meagan M. Wasfy (ORCID: https://orcid.org/0000-0003-0398-0481)
- Carolyn VanAtta (ORCID: https://orcid.org/0000-0001-5043-2782)
- Clíodhna McHugh (ORCID: https://orcid.org/0000-0001-9960-1954)
- Albree Tower‐Rader
- Mark Schoenike
- Sarah Gustus
- Bradley J. Petek (ORCID: https://orcid.org/0000-0002-6603-2262)
- Michael A. Fifer (ORCID: https://orcid.org/0000-0002-8363-445X)
- Jasmine B Kennett
- Marcelo F. DiCarli
Institutions
- Brigham and Women's Hospital (US)
- Oregon Health & Science University (US)
- John F. Kennedy University (US)
- Trinity College Dublin (IE)
- Massachusetts General Hospital (US)
- St. James's Hospital (IE)
- John F. Kennedy Medical Center (US)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1093/eurjpc/zwaf177
- Citations
- 3
- Primary Topic
- Cardiovascular Effects of Exercise
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- Norges Idrettshøgskole